191 related articles for article (PubMed ID: 3083745)
1. Association of systemic immune complexes, complement activation, and antibodies to Pseudomonas aeruginosa lipopolysaccharide and exotoxin A with mortality in cystic fibrosis.
Moss RB; Hsu YP; Lewiston NJ; Curd JG; Milgrom H; Hart S; Dyer B; Larrick JW
Am Rev Respir Dis; 1986 Apr; 133(4):648-52. PubMed ID: 3083745
[TBL] [Abstract][Full Text] [Related]
2. Serotype-specific serum IgG antibodies to lipopolysaccharides of Pseudomonas aeruginosa in cystic fibrosis: correlation to disease, subclass distribution, and experimental protective capacity.
Schaad UB; Lang AB; Wedgwood J; Buehlamnn U; Fuerer E
Pediatr Res; 1990 May; 27(5):508-13. PubMed ID: 2111907
[TBL] [Abstract][Full Text] [Related]
3. Immunoglobulin G antibodies to Pseudomonas aeruginosa lipopolysaccharides and exotoxin A in patients with cystic fibrosis or bacteremia.
Brauner A; Cryz SJ; Granström M; Hanson HS; Löfstrand L; Strandvik B; Wretlind B
Eur J Clin Microbiol Infect Dis; 1993 Jun; 12(6):430-6. PubMed ID: 8359163
[TBL] [Abstract][Full Text] [Related]
4. Nonopsonic antibodies in cystic fibrosis. Pseudomonas aeruginosa lipopolysaccharide-specific immunoglobulin G antibodies from infected patient sera inhibit neutrophil oxidative responses.
Eichler I; Joris L; Hsu YP; Van Wye J; Bram R; Moss R
J Clin Invest; 1989 Dec; 84(6):1794-804. PubMed ID: 2512330
[TBL] [Abstract][Full Text] [Related]
5. Circulating immune complexes, antibodies to Pseudomonas aeruginosa, and pulmonary status in cystic fibrosis.
Lagacé J; Mercier J; Fréchette M; Fournier D; Dubreuil M; Lamarre A; Lapointe JR; Montplaisir S
J Clin Lab Immunol; 1989 Sep; 30(1):7-11. PubMed ID: 2534928
[TBL] [Abstract][Full Text] [Related]
6. Distribution of antibodies to selected antigens of Pseudomonas aeruginosa in children and young adults with cystic fibrosis.
Gaweł J; Pogorzelski A; Działek-Smętek E; Sochań B; Ligarska R; Lącka M; Mazurek H
Pneumonol Alergol Pol; 2014; 82(4):336-41. PubMed ID: 24964236
[TBL] [Abstract][Full Text] [Related]
7. Prognostic implications of circulating immune complexes and Pseudomonas aeruginosa-specific antibodies in cystic fibrosis.
Dasgupta MK; Lam J; Döring G; Harley FL; Zuberbuhler P; Lam K; Reichert A; Costerton JW; Dossetor JB
J Clin Lab Immunol; 1987 May; 23(1):25-30. PubMed ID: 3112403
[TBL] [Abstract][Full Text] [Related]
8. [Anti-Pseudomonas aeruginosa antibodies, circulating immune complexes, and anticytoplasm antibodies of neutrophils in patients with cystic fibrosis with and without Pseudomonas aeruginosa colonization].
Chiappini E; Taccetti G; Campana S; Turchini S; Marianelli L
Pediatr Med Chir; 2001; 23(1):27-30. PubMed ID: 11486418
[TBL] [Abstract][Full Text] [Related]
9. Immunoglobulin-G subclasses in cystic fibrosis. IgG2 response to Pseudomonas aeruginosa lipopolysaccharide.
Fick RB; Olchowski J; Squier SU; Merrill WW; Reynolds HY
Am Rev Respir Dis; 1986 Mar; 133(3):418-22. PubMed ID: 3082264
[TBL] [Abstract][Full Text] [Related]
10. Detection by enzyme-linked immunosorbent assays of antibody specific for Pseudomonas proteases and exotoxin A in sera from cystic fibrosis patients.
Jagger KS; Robinson DL; Franz MN; Warren RL
J Clin Microbiol; 1982 Jun; 15(6):1054-8. PubMed ID: 6809785
[TBL] [Abstract][Full Text] [Related]
11. Lipopolysaccharide (LPS), LPS-immune complexes and cytokines as inducers of pulmonary inflammation in patients with cystic fibrosis and chronic Pseudomonas aeruginosa lung infection.
Kronborg G
APMIS Suppl; 1995; 50():1-30. PubMed ID: 7756034
[TBL] [Abstract][Full Text] [Related]
12. Antibody responses to lipid A, core, and O sugars of the Pseudomonas aeruginosa lipopolysaccharide in chronically infected cystic fibrosis patients.
Kronborg G; Fomsgaard A; Galanos C; Freudenberg MA; Høiby N
J Clin Microbiol; 1992 Jul; 30(7):1848-55. PubMed ID: 1378455
[TBL] [Abstract][Full Text] [Related]
13. Antibody response to Burkholderia cepacia in patients with cystic fibrosis colonized with Burkholderia cepacia and Pseudomonas aeruginosa.
Hendry J; Butler S; Elborn JS; Govan JR; Nelson J; Shale DJ; Webb AK
J Infect; 2000 Mar; 40(2):164-70. PubMed ID: 10841094
[TBL] [Abstract][Full Text] [Related]
14. Serum IgG and sputum IgA antibody to core lipopolysaccharide antigen from Pseudomonas cepacia in patients with cystic fibrosis.
Nelson JW; Butler SL; Brown PH; Greening AP; Govan JR
J Med Microbiol; 1993 Jul; 39(1):39-47. PubMed ID: 7686977
[TBL] [Abstract][Full Text] [Related]
15. Relative increase in IgG antibodies to Pseudomonas aeruginosa 60-kDa GroEL in prediabetic patients with cystic fibrosis.
Jensen P; Johansen HK; Lanng S; Høiby N
Pediatr Res; 2001 Mar; 49(3):423-8. PubMed ID: 11228271
[TBL] [Abstract][Full Text] [Related]
16. IgA and IgG antibodies against surface antigens of Pseudomonas aeruginosa in sputum and serum from patients with cystic fibrosis.
Schiøtz PO; Høiby N; Permin H; Wiik A
Acta Pathol Microbiol Scand C; 1979 Jun; 87C(3):229-33. PubMed ID: 113981
[TBL] [Abstract][Full Text] [Related]
17. Immunoglobulin allotypes and IgG subclass antibody response to Pseudomonas aeruginosa antigens in chronically infected cystic fibrosis patients.
Pressler T; Pandey JP; Espersen F; Pedersen SS; Fomsgaard A; Koch C; Høiby N
Clin Exp Immunol; 1992 Nov; 90(2):209-14. PubMed ID: 1424275
[TBL] [Abstract][Full Text] [Related]
18. Immune complexes and humoral response to Pseudomonas aeruginosa in cystic fibrosis.
Moss RB; Lewiston NJ
Am Rev Respir Dis; 1980 Jan; 121(1):23-9. PubMed ID: 6766286
[TBL] [Abstract][Full Text] [Related]
19. Prospective study of serum antibodies to Pseudomonas aeruginosa exoproteins in cystic fibrosis.
Hollsing AE; Granström M; Vasil ML; Wretlind B; Strandvik B
J Clin Microbiol; 1987 Oct; 25(10):1868-74. PubMed ID: 3117842
[TBL] [Abstract][Full Text] [Related]
20. Circulating immune complexes in cystic fibrosis.
Berdischewsky M; Pollack M; Young LS; Chia D; Osher AB; Barnett EV
Pediatr Res; 1980 Jun; 14(6):830-3. PubMed ID: 6773019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]